<DOC>
	<DOCNO>NCT02958436</DOCNO>
	<brief_summary>The primary object study evaluate safety tolerability single ascend intravenous ( IV ) subcutaneous ( SC ) dose REGN3500 healthy adult male female</brief_summary>
	<brief_title>A Study Intravenously Subcutaneously Administered REGN3500 Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Body Mass Index &lt; /= 33 kg/m2 In good health base medical history , physical examination , vital sign , laboratory test Normal electrocardiogram ( ECG ) blood pressure Able comply clinic visit studyrelated procedure Able sign inform consent Significant abnormalities hematology , clinical chemistry , urinalysis , medical history Current smoker recent history ( within 3 month ) History tuberculosis , HIV , hepatic disease Known sensitivity doxycycline ingredient study drug History multiple/severe allergies Pregnant breastfeed woman , currently use adequate contraception Participation another investigational drug study within 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>REGN3500</keyword>
</DOC>